TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1542501

Group type: EXPERIMENTAL
Intervention: Drug intake during pregnancy (excluding pregnancy supplements)
Number of subjects: 10698

Group type: EXPERIMENTAL
Intervention: Hormonal support therapy
Number of subjects: 10698

Group type: EXPERIMENTAL
Intervention: Human teratogenic drugs
Number of subjects: 10698

Group type: COMPARATOR
Intervention: General drug use during pregnancy
Number of subjects: 10698
Study: 3890282

Group type: EXPERIMENTAL
Intervention: Trimethoprim (300 mg twice daily for five days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Co-trimoxazole (two tablets twice daily for five days)
Number of subjects: 20
Study: 30605517

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Mindfulness Meditation (MM)
Number of subjects: 69
Study: 29273691

Group type: EXPERIMENTAL
Intervention: Subtemporal approach
Number of subjects: 47

Group type: COMPARATOR
Intervention: Transsylvian approach
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Left side of surgery
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Overall (both approaches)
Number of subjects: 47
Study: 27029912

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) (n = 48)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT) (n = 48)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control Group (CBT)
Number of subjects: 96
Study: 24162138

Group type: EXPERIMENTAL
Intervention: Single-stage laparoscopic CBD exploration and cholecystectomy (group 1)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP) for endoscopic extraction of CBD stones followed by laparoscopic cholecystectomy (group 2)
Number of subjects: 168
Study: 22805100

Group type: EXPERIMENTAL
Intervention: 60 mg/d oral prednisone for 14 days with a 5‐day taper (121 patients)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 4 IT doses for 14 days of 40 mg/ml methylprednisolone (129 patients)
Number of subjects: 250
Study: 20393355

Group type: EXPERIMENTAL
Intervention: Under-18 players
Number of subjects: 45

Group type: COMPARATOR
Intervention: Under-20 and Senior players
Number of subjects: 45

Group type: COMPARATOR
Intervention: Senior players
Number of subjects: 45

Group type: COMPARATOR
Intervention: Yo-Yo intermittent recovery test (Yo-Yo IR1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Point guards
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Power forwards and centers
Number of subjects: 45
Study: 18759980

Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 44

Group type: COMPARATOR
Intervention: Pentobarbital
Number of subjects: 44
Study: 16013911

Group type: EXPERIMENTAL
Intervention: Active rTMS (20 Hz or 5 Hz)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study: 12432178

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (BC; 60 g day-1)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Concentrated whey protein powder (WP; 60 g day-1)
Number of subjects: 13
Study: 10839068

Group type: EXPERIMENTAL
Intervention: Structured teaching intervention on RN delegation decision making
Number of subjects: 0
Study: 8947821

Group type: EXPERIMENTAL
Intervention: Modified Ham's F10 medium (MM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified Ham's F10 medium with 0.5 mM glucose (LGMM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal Ham's F10
Number of subjects: 0
Study: 1471582

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo (1,000 IU of vitamin A)
Number of subjects: 109
Study: 6744778

Group type: EXPERIMENTAL
Intervention: 25 mg HCTZ/amiloride 2.5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25 mg HCTZ alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 25 mg HCTZ/amiloride 2.5 mg (higher dose)
Number of subjects: 30
Study: 30702519

Group type: EXPERIMENTAL
Intervention: Daily protein-calorie supplement and micronutrient supplement
Number of subjects: 74

Group type: COMPARATOR
Intervention: Micronutrient supplement only
Number of subjects: 74
Study: 30201853

Group type: EXPERIMENTAL
Intervention: 48 g Casein Protein (CP)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 24 g Casein Protein (CP)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 24 g Whey Protein (WP)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 48 g Whey Protein (WP)
Number of subjects: 9
Study: 26890094

Group type: EXPERIMENTAL
Intervention: Neuronavigated continuous theta burst stimulation (cTBS) over the left primary auditory cortex
Number of subjects: 23

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neuronavigated continuous theta burst stimulation (cTBS)
Number of subjects: 23
Study: 24650926

Group type: EXPERIMENTAL
Intervention: Aortic pressure-guided treatment (active, n=23)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional therapy (control, n=27)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (active and control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Aortic pressure-guided treatment (active)
Number of subjects: 50
Study: 22956578

Group type: EXPERIMENTAL
Intervention: IgA1 purified from IgAN patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-aggregated IgA1 purified from IgAN patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological inhibition of SYK
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Knockdown of SYK by small interfering RNA
Number of subjects: 0
Study: 19858314

Group type: EXPERIMENTAL
Intervention: Self-efficacy for fruit consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-efficacy for vegetable consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proxy efficacy to influence parents to make FV available
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proxy efficacy to influence after-school staff to make FV available
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement invariance across gender, SES, and ethnicity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population heterogeneity tests
Number of subjects: 0
Study: 17870636

Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3-day oral quinine-clindamycin
Number of subjects: 0
Study: 16216093

Group type: EXPERIMENTAL
Intervention: Formocresol (FC)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (CA)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Ferric sulphate (FS)
Number of subjects: 104
Study: 12244905

Group type: EXPERIMENTAL
Intervention: Transparent occlusive dressing applied to the insertion site, not removed for 7 days unless signs of local infection (Group I)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Daily site care with povidone-iodine 10% solution and new sterile gauze (Group II)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Insertion site infection
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Age younger than 60 years
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition administration
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Coexisting malignancy or diabetes mellitus, duration of catheter, antibiotics use
Number of subjects: 72
Study: 10416046

Group type: EXPERIMENTAL
Intervention: CoQ10 100 mg bid
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 7580834

Group type: EXPERIMENTAL
Intervention: HGP‐30 vaccine (10 and 25 micrograms/kg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: HGP‐30 vaccine (50 and 100 micrograms/kg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: HGP‐30 vaccine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Non-immunized subject
Number of subjects: 38
Study: 2164934

Group type: EXPERIMENTAL
Intervention: Ketoconazole tablets every 8 hours for six doses
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol patch
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of ketoconazole and transdermal estradiol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (normotensive)
Number of subjects: 24
Study: 6942844

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Clofibrate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Comparison of Gemfibrozil and Clofibrate
Number of subjects: 10
Study: 31865749

Group type: EXPERIMENTAL
Intervention: Recruitment strategies including prior relationships with local health department, alignment of project goals with practice priorities, and monetary incentives.
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Retention strategies including ongoing multifaceted communication strategy.
Number of subjects: 257
Study: 31422390

Group type: EXPERIMENTAL
Intervention: Dexamethasone plus antibiotic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Antibiotic and placebo (Control)
Number of subjects: 60
Study: 29525907

Group type: COMPARATOR
Intervention: Intralesional injection of 10 mg/ml triamcinolone (steroid)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intralesional injection of 1 ml autologous platelet-rich plasma (PRP)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both treatments (PRP and ILS)
Number of subjects: 9
Study: 26574953

Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5 mg od)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Finasteride (5 mg od)
Number of subjects: 12
Study: 24964392

Group type: EXPERIMENTAL
Intervention: Darunavir/cobicistat fixed-dose combination (FDC) 800 mg/150 mg
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Darunavir/cobicistat FDC with high-fat breakfast
Number of subjects: 133

Group type: COMPARATOR
Intervention: Darunavir (800 mg) and cobicistat (150 mg) as single agents
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs) related to darunavir
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs) related to cobicistat
Number of subjects: 133
Study: 22368231

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX) treatment with methotrexate after 1 g infusion on days 1 and 15
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Rituximab (RTX) treatment in rheumatoid factor-positive patients
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Multivariate analysis of V allele carriage
Number of subjects: 111
Study: 20022717

Group type: EXPERIMENTAL
Intervention: Massage therapy by mothers plus skin‐to‐skin care (Intervention Group)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Skin‐to‐skin care (Control Group)
Number of subjects: 73
Study: 17404083

Group type: EXPERIMENTAL
Intervention: Ketoconazole treatment
Number of subjects: 103
Study: 16334808

Group type: EXPERIMENTAL
Intervention: Enprostil 25 microg b.i.d. and cimetidine 400 mg b.i.d. for 8 weeks
Number of subjects: 171

Group type: COMPARATOR
Intervention: Cimetidine 400 mg b.i.d. alone for 8 weeks
Number of subjects: 171
Study: 12494804

Group type: EXPERIMENTAL
Intervention: Bilateral ilioinguinal nerve block with 15 ml x 2 of 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Subcutaneous 1 mg kg‐1 of tramadol
Number of subjects: 60
Study: 9798447

Group type: EXPERIMENTAL
Intervention: 3 Richards screws
Number of subjects: 268

Group type: COMPARATOR
Intervention: 2 Uppsala screws
Number of subjects: 268
Study: 7710022

Group type: EXPERIMENTAL
Intervention: Spontaneous ventilation with a laryngeal mask
Number of subjects: 40

Group type: COMPARATOR
Intervention: Controlled ventilation with a tracheal tube
Number of subjects: 40
Study: 2534416

Group type: EXPERIMENTAL
Intervention: 10 mg nicorandil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20 mg nicorandil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30 mg nicorandil
Number of subjects: 12
Study: 16256

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aluminium hydroxide
Number of subjects: 0
Study: 31289887

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation during training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation during training
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 32
Study: 28603907

Group type: EXPERIMENTAL
Intervention: 3D-printed bronchoscopy simulator
Number of subjects: 30

Group type: COMPARATOR
Intervention: Commercially available bronchial tree simulators
Number of subjects: 30
Study: 25722380

Group type: EXPERIMENTAL
Intervention: trabectedin + PLD
Number of subjects: 264

Group type: COMPARATOR
Intervention: PLD
Number of subjects: 264
Study: 23812516

Group type: EXPERIMENTAL
Intervention: Infant cereal A
Number of subjects: 19

Group type: COMPARATOR
Intervention: Infant cereal B
Number of subjects: 19
Study: 20685043

Group type: EXPERIMENTAL
Intervention: 1mg IV cortisol infusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 19333947

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40-80 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16705579

Group type: EXPERIMENTAL
Intervention: Posaconazole
Number of subjects: 428
Study: 15462107

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 15
Study: 11345280

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fexofenadine 180 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fexofenadine 120 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 9404206

Group type: EXPERIMENTAL
Intervention: 28 kV (with grid)
Number of subjects: 25078

Group type: COMPARATOR
Intervention: 25 kV (no grid)
Number of subjects: 25078
Study: 7694321

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Mono-chemotherapy
Number of subjects: 127

Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 127
Study: 3308728

Group type: EXPERIMENTAL
Intervention: Intravitreal silicone oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gas (20% C3F8 or 30% C4F8)
Number of subjects: 0
Study: 28960913

Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (SQ-LNS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Household socioeconomic status, birth outcomes, child growth, maternal and child morbidity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heads of household
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personal experience using SQ-LNS
Number of subjects: 0
Study: 27571371

Group type: EXPERIMENTAL
Intervention: Fixed labial appliances
Number of subjects: 44

Group type: COMPARATOR
Intervention: Clear aligners (Invisalign)
Number of subjects: 44
Study: 24630479

Group type: EXPERIMENTAL
Intervention: Stress management program (10 sessions)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (10 students and 10 professionals)
Number of subjects: 53
Study: 23571496

Group type: EXPERIMENTAL
Intervention: Pegylated filgrastim 100 µg/kg
Number of subjects: 337

Group type: COMPARATOR
Intervention: Filgrastim 5 µg/kg/day
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Pegylated filgrastim
Number of subjects: 337

Group type: COMPARATOR
Intervention: Filgrastim
Number of subjects: 337
Study: 20033901

Group type: EXPERIMENTAL
Intervention: Brief problem-solving treatment by primary care doctors (PST-PC)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Group video-viewing (placebo)
Number of subjects: 299
Study: 18248543

Group type: EXPERIMENTAL
Intervention: Group-based exercise program (10-week duration)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Home exercise (control)
Number of subjects: 68
Study: 16919061

Group type: EXPERIMENTAL
Intervention: Medication overuse headache (MOH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Analgesics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Triptan-induced medication overuse headache (MOH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 60

Group type: COMPARATOR
Intervention: Episodic migraine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Depression without headache
Number of subjects: 60
Study: 15265052

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (3 sessions)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (3 hyperbaric air treatments)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (hyperbaric air treatments)
Number of subjects: 40
Study: 11413265

Group type: EXPERIMENTAL
Intervention: Telemedicine (TM)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Face to face (FF)
Number of subjects: 168
Study: 9255753

Group type: EXPERIMENTAL
Intervention: Menorest 50
Number of subjects: 43

Group type: COMPARATOR
Intervention: Systen 50 (Evorel 50)
Number of subjects: 43
Study: 8331200

Group type: EXPERIMENTAL
Intervention: Single dose of 20 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Single dose of 40 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Single dose of 80 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multiple dose administration of 40 mg/day for 5 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multiple dose administration of 80 mg/day for 5 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multiple dose administration of 160 mg/day for 5 days
Number of subjects: 24
Study: 3571773

Group type: EXPERIMENTAL
Intervention: Nebulized bitolterol mesylate (0.2%)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Nebulized isoproterenol hydrochloride (0.3%)
Number of subjects: 183
Study: 31244992

Group type: EXPERIMENTAL
Intervention: Active TENS (n = 49) applied from L3-S1 at a frequency of 65-100 Hz, pulse width of 100-200 usec, turned on 2 min before and maintained during the self-paced walking test (SPWT).
Number of subjects: 104

Group type: COMPARATOR
Intervention: De-tuned TENS (n = 51) applied similarly for 30 s followed by ramping down to zero stimulus, turned off before and during the SPWT.
Number of subjects: 104
Study: 28970147

Group type: EXPERIMENTAL
Intervention: Fructans (0.5 g/kg; maximum, 19 g)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Maltodextrin (placebo)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Fructans
Number of subjects: 23

Group type: COMPARATOR
Intervention: Maltodextrin
Number of subjects: 23
Study: 26169710

Group type: EXPERIMENTAL
Intervention: Cephalad-caudad blunt expansion
Number of subjects: 112

Group type: COMPARATOR
Intervention: Transverse blunt expansion
Number of subjects: 112
Study: 25205759

Group type: EXPERIMENTAL
Intervention: Endometrial aspiration (EA)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-endometrial aspiration (non-EA)
Number of subjects: 300
Study: 22684198

Group type: EXPERIMENTAL
Intervention: Isokinetic exercise (IE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Progressive resistive exercise (PRE)
Number of subjects: 40
Study: 20414673

Group type: EXPERIMENTAL
Intervention: Acute hypoxia (simulated altitude of 4,500 m)
Number of subjects: 23
Study: 18008246

Group type: EXPERIMENTAL
Intervention: Zidovudine prophylaxis
Number of subjects: 1437
Study: 16344230

Group type: EXPERIMENTAL
Intervention: CT-based attenuation correction (AC)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: SPECT images with AC
Number of subjects: 118

Group type: COMPARATOR
Intervention: SPECT images without AC
Number of subjects: 118
Study: 12492188

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg p.o. b.i.d. for 6 weeks
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo capsules p.o. b.i.d. for 6 weeks
Number of subjects: 140
Study: 9804720

Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 109

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 109
Study: 7623755

Group type: EXPERIMENTAL
Intervention: Test site with Plaque Index (P1I) = 0
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control site with highest P1I score (2 or 3)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both test and control sites
Number of subjects: 33
Study: 2695806

Group type: EXPERIMENTAL
Intervention: 1.5 mg telenzepine once daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 3 mg telenzepine once daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 5 mg telenzepine once daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 1.5 mg and 3 mg telenzepine
Number of subjects: 120
Study: 780300

Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 30952565

Group type: EXPERIMENTAL
Intervention: Integrated care centres providing HIV testing, prevention, and treatment services.
Number of subjects: 23990

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 23990

Group type: EXPERIMENTAL
Intervention: Integrated care centre exposure (visited at least once).
Number of subjects: 23990
Study: 28592250

Group type: EXPERIMENTAL
Intervention: Mass Testing and Treatment (MTaT) approach
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 10
Study: 25983237

Group type: EXPERIMENTAL
Intervention: Tailored Physical Activity (TPA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Reference group (REF)
Number of subjects: 54
Study: 23775515

Group type: EXPERIMENTAL
Intervention: 2% diltiazem gel
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 62
Study: 21665103

Group type: EXPERIMENTAL
Intervention: Bowen Technique
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120